- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/192 - Radicals derived from carboxylic acids from aromatic carboxylic acids
Patent holdings for IPC class C07D 295/192
Total number of patents in this class: 364
10-year publication summary
53
|
32
|
34
|
36
|
19
|
44
|
21
|
14
|
15
|
5
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Janssen Pharmaceutica N.V. | 3396 |
10 |
Agios Pharmaceuticals, Inc | 216 |
10 |
Imago Biosciences, Inc. | 38 |
8 |
Akebia Therapeutics, Inc. | 113 |
7 |
King Abdulaziz University | 508 |
7 |
PTC Therapeutics, Inc. | 483 |
6 |
AstraZeneca AB | 2928 |
5 |
Dongguk University Industry-Academic Cooperation Foundation | 429 |
5 |
The University of Liverpool | 303 |
5 |
VALO Health, Inc. | 172 |
5 |
Board of Regents, The University of Texas System | 5763 |
4 |
The Trustees of Columbia University in the City of New York | 3563 |
4 |
Mayo Foundation for Medical Education and Research | 3199 |
4 |
Annji Pharmaceutical Co., Ltd. | 15 |
4 |
Canopy Growth Corporation | 219 |
4 |
Owen-barry Pharmaceuticals Inc. | 9 |
4 |
Novartis AG | 10886 |
3 |
Centre National de La Recherche Scientifique | 10408 |
3 |
The Johns Hopkins University | 5652 |
3 |
Catabasis Pharmaceuticals, Inc. | 36 |
3 |
Other owners | 260 |